WA
KIDS icon

Wasatch Advisors’s OrthoPediatrics KIDS Stock Holding History

Wasatch Advisors’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Buy
515,677
+186,357
+57% +$3.24M 0.06% 142
2026
Q1 		$5.23M Buy
329,320
+39,451
+14% +$689K 0.03% 161
2025
Q4 		$5.15M Sell
289,869
-14,242
-5% -$249K 0.03% 174
2025
Q3 		$5.64M Sell
304,111
-11,543
-4% -$238K 0.03% 180
2025
Q2 		$6.78M Sell
315,654
-402,223
-56% -$8.69M 0.04% 174
2025
Q1 		$17.7M Buy
717,877
+21,559
+3% +$532K 0.1% 132
2024
Q4 		$16.1M Buy
696,318
+223,217
+47% +$5.58M 0.08% 139
2024
Q3 		$12.8M Sell
473,101
-62,195
-12% -$1.88M 0.06% 142
2024
Q2 		$15.4M Buy
535,296
+33,986
+7% +$1.04M 0.08% 138
2024
Q1 		$14.6M Buy
501,310
+87,657
+21% +$2.45M 0.08% 146
2023
Q4 		$13.4M Buy
413,653
+26,073
+7% +$756K 0.07% 140
2023
Q3 		$12.4M Sell
387,580
-18,076
-4% -$696K 0.08% 136
2023
Q2 		$17.8M Buy
405,656
+14,345
+4% +$661K 0.11% 135
2023
Q1 		$17.3M Buy
391,311
+5,176
+1% +$229K 0.11% 138
2022
Q4 		$15.3M Buy
386,135
+243
+0.1% +$10.1K 0.1% 149
2022
Q3 		$17.8M Sell
385,892
-70,317
-15% -$3.45M 0.12% 144
2022
Q2 		$19.7M Sell
456,209
-26,855
-6% -$1.23M 0.12% 135
2022
Q1 		$26.1M Sell
483,064
-16,373
-3% -$836K 0.13% 137
2021
Q4 		$29.9M Buy
499,437
+4,503
+0.9% +$280K 0.12% 145
2021
Q3 		$32.4M Sell
494,934
-74,287
-13% -$4.82M 0.13% 136
2021
Q2 		$36M Sell
569,221
-113,639
-17% -$6.53M 0.15% 134
2021
Q1 		$33.3M Buy
682,860
+271,528
+66% +$13M 0.15% 122
2020
Q4 		$17M Buy
411,332
+46,758
+13% +$2.14M 0.08% 156
2020
Q3 		$16.7M Sell
364,574
-40,639
-10% -$1.89M 0.11% 140
2020
Q2 		$17.7M Buy
405,213
+108,941
+37% +$4.9M 0.13% 131
2020
Q1 		$11.7M Sell
296,272
-67,607
-19% -$3.03M 0.12% 120
2019
Q4 		$17.1M Buy
363,879
+2,993
+0.8% +$116K 0.14% 120
2019
Q3 		$12.7M Buy
360,886
+13,288
+4% +$460K 0.12% 123
2019
Q2 		$13.6M Buy
347,598
+76,534
+28% +$3.09M 0.13% 122
2019
Q1 		$12M Sell
271,064
-86,300
-24% -$3.28M 0.13% 115
2018
Q4 		$12.5M Sell
357,364
-20,988
-6% -$665K 0.17% 98
2018
Q3 		$13.9M Sell
378,352
-22,697
-6% -$695K 0.16% 98
2018
Q2 		$10.7M Buy
401,049
+165,234
+70% +$3.53M 0.13% 111
2018
Q1 		$3.55M Buy
235,815
+74,666
+46% +$1.32M 0.05% 180
2017
Q4 		$3.09M Buy
+161,149
New +$3.08M 0.04% 186

Other funds holding KIDS

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Wasatch Advisors's KIDS Position: Q2 2026 in Review

Wasatch Advisors increased its OrthoPediatrics (KIDS) stake by 57% in Q2 2026, buying an estimated $3.24M and bringing the position to 515,677 shares worth $9.86M. The position accounts for 0.06% of the portfolio, ranked #142.

Wasatch Advisors first reported a position in KIDS in Q4 2017 and has held it in 35 quarters since. The position peaked at $36M in Q2 2021. 9 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Wasatch Advisors held 515,677 shares of OrthoPediatrics worth $9.86M as of Q2 2026.
  • Wasatch Advisors bought 186,357 OrthoPediatrics shares in Q2 2026, an estimated $3.24M.
  • OrthoPediatrics made up 0.06% of Wasatch Advisors's portfolio in Q2 2026, its #142 holding.
  • Wasatch Advisors first reported a position in OrthoPediatrics in Q4 2017 and has held it in 35 quarters since.
  • Wasatch Advisors's OrthoPediatrics position peaked at $36M in Q2 2021.
  • 9 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.